Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ: IRTC )

112.11 -0.08 (-0.07%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
IRHYTHM SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTC
From Kahn Swick & Foti, LLC
Via Business Wire
IRTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
A Glimpse Into The Expert Outlook On iRhythm Technologies Through 6 Analysts
Via Benzinga
Analyst Expectations for iRhythm Technologies's Future
Via Benzinga
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of iRhythm Technologies, Inc. (IRTC) Investors
From Kirby McInerney LLP
Via Business Wire
IRTC INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead the iRhythm Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
IRHYTHM TECHNOLOGIES, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against iRhythm Technologies, Inc. (NASDAQ: IRTC)
From Bernstein Liebhard LLP
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About iRhythm Technologies
Via Benzinga
Analyst Ratings for iRhythm Technologies
Via Benzinga
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
7 Healthcare Stocks Taking Medicine to the Next Level
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
From iRhythm
Via GlobeNewswire
Analyst Ratings for iRhythm Technologies
Via Benzinga
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio® monitor and ZEUS System
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services... 
From iRhythm
Via GlobeNewswire
New Research Presented at American Heart Association’s 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
Study findings from a collaboration with Duke Health found that a model that incorporates ECG data from long-term continuous monitoring resulted in more accurate prediction of heart failure... 
From iRhythm
Via GlobeNewswire
What 11 Analyst Ratings Have To Say About iRhythm Technologies
Via Benzinga
iRhythm Launches Next Generation Zio Monitor and Enhanced Zio Service: Its Smallest, Lightest and Thinnest Cardiac Monitor
From iRhythm
Via GlobeNewswire
Revolutionizing Tech: 7 Growth Stocks to Grab for Dynamic Returns
For investors that want to position themselves for the future, these compelling top growth stocks to buy could be enticing. 
Via InvestorPlace
IRhythm Technologies' Cost Efficiency And Potential Entry Into The Japanese Market Earn Analyst Applaud
Truist Securities analyst Richard Newitter reiterated a Buy rating on IRhythm Technologies, Inc. (NASDAQ: IRTC), 
Via Benzinga
Strong Zio AT Business Growth Propels iRhythm's Q2 Revenue Surge, Analysts Say Warning Letter Manageable
iRhythm Technologies Inc's (NASDAQ: IRTC) revenue of $124.1 million increased 21.6% Y/Y, beating the consensus of $120.3 
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
iRhythm Technologies' Market-Leading ZioService to Dominate ACM Sector: Analyst Initiates with Outperform Rating
Baird initiated coverage on iRhythm Technologies Inc (NASDAQ: IRTC) with an Outperform rating and  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
7 Robotics Stocks to Target for Triple-Digit Returns in 2023
Harness the power of robotics innovation for your portfolio and invest in these robotics stocks for high returns. 
Via InvestorPlace
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular? 
Via News Direct
Exposures Product Safety
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include viol 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.